Abstract
Objective: To synthesize the main scientific evidences related to the effects of different protocols of therapy by exercise in patients submitted to cardiac transplantation. Methodology: The research was carried out from the databases MEDLINE and EMBASE via Ovid from 2000 until October 1, 2016, the accumulated index of the literature for nurses and other health professionals (CINAHL), LILACS and Cochrane Central of controlled studies), using the descriptors: heart transplantation, exercise, physiotherapy, physical therapy and physical activity, and no language restriction was imposed for the research, and only the studies developed in the last 16 years were used. Results: 67 articles were found in the initial search. From the 8 articles selected, it was verified that the exercise improved the capacity and the physical performance of individuals in the postoperative period of heart transplant surgeries. Conclusion: Evidence indicates that exercise under the supervision of the professional physiotherapist showed beneficial effects in the rehabilitation of individuals who are in the period after cardiac transplantation.
Highlights
Heart Failure (HF), a clinical condition characterized by the heart’s difficulty in assuring proper cardiac output, is due to risk factors such as coronary artery disease (CAD), systemic arterial hypertension, diabetes mellitus and dyslipidemias[1]
After analysis by two researchers, of the 67 studies initially identified, 59 articles were excluded for several reasons, including studies developed in different clinical settings, those that did not use physical exercise as a therapeutic measure, or did not present an appropriate methodological design
All eight studies included in this literature review discuss the use of physical exercise in the post-transplantation of the heart[5,6,7,8,9,10,11,12]
Summary
Heart Failure (HF), a clinical condition characterized by the heart’s difficulty in assuring proper cardiac output, is due to risk factors such as coronary artery disease (CAD), systemic arterial hypertension, diabetes mellitus and dyslipidemias[1]. According to DATASUS, there are approximately 2 million patients with HF in Brazil. It is estimated that in 2025, Brazil will have about 30 million elderly people, culminating in the increase of cases and expenses with the syndrome[2]. Despite the increasing advances in clinical and pharmacological interventions, increase in quality and life expectancy, many individuals with HF persist with evolution refractory to conservative treatment and require cardiac transplantation. According to Mangini and colleagues, cardiac transplantation is aimed at improving the quality of life and increasing survival. Some variables can be used to predict the prognosis of patients undergoing this intervention, such as: oxygen consumption and the equivalent of ventilation of carbon dioxide. Patients with chagasic cardiomyopathy have a worse outcome after surgery[3]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
